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ABSTRACT 
Traditionally several species of Memecylon are used to cure skin problems. However, scientific validation of the plant as a modern medicine is 
lacking. Therefore, in the present study methanolic extracts of three species of Memecylon i.e., M. umbellatum, M. talbotianum and M. malabaricum 
were assessed for their antioxidant, anti-microbial, DNA protection capacities, 5-lipoxygenase and human cyclooxygenase (COX-2) inhibition.  
Methods: 1,1-Diphenyl-2-picrylhydrazyl (DPPH) and 2,2’-azinobis-(3-ethylbenzthiazoline-6-sulfonic acid) ABTS radical scavenging capacities for 
extracts in dose range of 50 μg/mL - 10 mg/mL were measured. 15-Lipoxygenase inhibition for these extracts at 10 - 200 μg/mL dose was studied. 
Human cyclooxygenase-2 was recorded for doses 10 and 50 µg/mL. DNA-nicking assay at 10 μg was recorded. Cell cytotoxicity was recorded by 
colorimetric MTT assay using doxorubicin as control for extracts (50 - 500 μg/mL).  
Results: The IC50 values for scavenging the DPPH radical ranged from 0.11 to 0.17 mg/mL and those for the ABTS radical cation from 2.1 to 3.7 
mg/mL for the extracts. M. malabaricum leaf extract exhibited highest lipoxygenase inhibition capacity with an IC50 value of 29.87 µg/mL. It also 
inhibited human COX-2 (80.6 % at 50 µg/mL). Methanolic leaf extracts could prevent DNA nicking by hydroxyl radicals, produced in the Fenton 
reaction. M. malabaricum leaf extracts inhibited growth of Klebsiella pneumonia, Staphylococcus aureus and Escherichia coli.  
Conclusion: This study forms initial screening of these plants with further studies directed towards identification of bioactive molecules as potential 
lead candidates.  
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INTRODUCTION 
In India, Western Ghats, is one of the 34 global biodiversity hotspots 
covering an area of 159,000 sq km with 4500 -15,000 plant species 
[1]. Almost 1,800 of these are endemic to the region and 500 plants 
have been identified to have potential medicinal value [2].  
The genus Memecylon L. (family Melastomataceae) comprises of 
about 300 species in the world, of which 30 species has been 
reported from India [3]. Memecylon umbellatum Burm. f., is a small 
and semi evergreen shrub or tree bearing several umbellate cymes. 
The leaves are used to treat conjunctivitis, and internally to treat 
leucorrhoea and gonorrhea [4]. Bark is used in the treatment of 
bruises [4, 5], snake bite [6] and skin diseases [7]. Pharmacological 
studies have shown biological activities such as anti-diabetic [8], 
anti-microbial activity [9] and anti-viral properties [10]. The plants 
contain a wide variety of phytoconstituents such as umbelactone, ß 
amyrine, oleanolic acid, ursolic acid, sitosterol and tannins [11].  
Memecylon talbotianum Brandis., endemic to the Western Ghats is a 
small tree mostly distributed in a small pocket of evergreen forest 
Central and south Sahyadri [12]. There have been no pharmaceutical 
reports on this specie of Memecylon. M.malabaricum Cogn. is 
traditionally used for the treatment of herpes. The young shoot tip 
paste along with cumin seeds is applied externally on the skin [13]. 
Methanol extracts of plants have been reported to have bactericidal 
activity against both Gram (+) and Gram (-) bacteria, and fungi [14]. 
A phytochemical study of the whole Memecylon genus reported the 
presence of 13 fatty acids, 12 methyltetradeconate, glucose, amino 
acids, carotenoids, a phenolic glycoside and possibly undefined 
saponins [15].  
Antioxidant property is considered an important biological activity. 
Phenolic compounds are well known to possess this activity [16] 
along with anti-inflammatory, anti-cancer and DNA protective 
effects [17].  
The present study was directed towards validation of ethno-
biologically important Memecylon species for their bioactive 
properties viz., antioxidant, anti-microbial, DNA protection, 5-
lipoxygenase and human cyclooxygenase-2 (COX-2) inhibition. 
MATERIALS AND METHODS 
Plants 
The whole plants of Memecylon umbellatum, M. talbotianum and M. 
malabaricum were collected from the Kigga region of the Western 
Ghats in, Chikmagalore District of Karnataka State. Herbarium 
specimens have been deposited in the herbarium at the Department 
of Studies in Biotechnology (M. umbellatum # IOE LP0001; M. 
talbotianum # IOE LP0002; M. malabaricum # IOE LP0003).  
Preparation of leaf extract  
Fresh leaves were thoroughly washed and dried under shade. They 
were ground to a coarse powder. Ten grams of ground material was 
suspended in 50 ml of methanol. The suspension was shaken for 60 
min at 25 ±2oC, sonicated for 75 min at room temperature (RT) and 
filtered. The extraction process was repeated three times. The 
solvent was evaporated in a SpeedVac (Savant SPD 2010, Thermo 
Scientific) and the extracts were stored in dark at 4oC.  
Chemicals and reagents 
Linoleic acid, 1,1-Diphenyl-2-picrylhydrazyl (DPPH), 15-
lipoxigenase (soybean), trypsin, chloramphenicol, 3-(4,5-
dimethylthylthiazol-2-yl)2,5-diphenyl tetrazolium bromide (MTT) 
and 2,2’-azinobis-(3-ethylbenzthiazoline-6-sulfonic acid) (ABTS) 
were purchased from Sigma-Aldrich (St. Louis, MO, USA). Quercetin, 
ascorbic acid and butylated hydroxyl toluene (BHT) were purchased 
from HiMedia (Bangalore, India). Human COX-2 inhibition kit was 
obtained from Cayman, Ann Arbor, MI, USA. pBR322 was obtained 
from Merck Biosciences (Bangalore, India). All solvents and reagents 
from various suppliers were of analytical grade.  
DPPH radical scavenging assay 
The traditional DPPH method [18] was modified and used in this 
study. A 300 µM DPPH solution was prepared in methanol. Methanol 
extracts of medicinal plants, ascorbic acid or butylated hydroxyl 
toluene (BHT) and quercetin diluted in methanol were used in the 
assay at different concentrations. Five microlitres of sample was 
added to the DPPH. solution (95 µL; absorbance of 0.68 ± 0.005 at 
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517 nm) in a microtiter plate and the mixture was incubated for 30 
min in dark at RT. Scavenging of DPPH was recorded as reduction in 
absorbance at 517 nm using a Spectra Max 340PC Multimode plate 
reader (Molecular Devices). Antioxidant activity was expressed as 
IC50 value.  
ABTS radical scavenging assay 
Antioxidant activity was measured using a UV-Vis 
spectrophotometer (Beckman Coulter, DU 730 Life Sciences) using 
the ABTS method [19]. The results were expressed in terms of total 
antioxidant capacity (TAC). The values are mean ± SD of three 
independent experiments.  
Estimation of total phenolic content 
The total phenolic content of each sample was estimated using the 
Folin–Ciocalteu colorimetric method [20]. The absorbance of the 
resulting blue color was measured at 760 nm with UV-Vis 
spectrophotometer (Beckman Coulter, DU 730 Life Sciences). 
Quantification was done using standard curve with gallic acid. 
Results were expressed as gram of Gallic acid equivalents (GAE) per 
100 gram of dry weight of sample (g GAE/100g DW). The values are 
mean ± SD of three independent experiments.  
Anti-microbial activity 
Test microorganisms and bioassay for anti-microbial activity 
All the microbial strains of human pathogens used in the anti-
microbial bioassay were procured from Institute of Microbial 
Technology (IMTECH), Chandigarh, India. These microbes include 
the gram negative bacteria such as Escherichia coli (MTCC 724), 
Klebsiella pneumonia (MTCC 661), Salmonella typhi (MTCC 733), 
Shigella flexneri (MTCC 1457); and gram positive bacteria such as 
Staphylococcus aureus MTCC 96 and Bacillus subtilis (MTCC 441). 
The agar well-diffusion method [21] was followed to determine the 
anti-microbial activity. Nutrient agar was used to culture the test 
microorganisms by spread plate method. Two 10 mm diameter discs 
were made and placed on these plates. Methanolic extract (10 µl of 
10 mg/ml) was loaded on 10 mm diameter sterile discs placed on 
agar medium under sterile conditions. Control experiments 
consisted of same volume of methanol. The plates were incubated at 
37oC for 15-18 h and the diameter of inhibition zones was recorded. 
The results were compared and analyzed against the same 
concentrations of chloramphenicol under similar conditions of 
experiment. Experiment was repeated thrice with three replicates 
each time and the average values were recorded. 
Lipoxygenase inhibition assay 
A spectrophotometric assay for determination of LOX activity was 
used as reported [22] with slight modification. Soybean 15-
lipoxygenase (15-LOX) was used for the assay. Inhibition 
experiments were run by measuring the loss of soybean 15-LOX 
activity (5 µg) with 0.2µM linoleic acid (Sigma) as the substrate 
prepared in solubilized state [22] in 0.2M borate buffer (pH 9.0). 
Inhibition studies in presence of various concentrations of extracts 
(10, 25, 50, 100, 200 µg/mL) and reference compound viz., quercetin 
was recorded at 234 nm using UV-Vis spectrophotometer (Beckman 
Coulter, DU 730 Life Sciences). The inhibitory effect of the extracts 
was also expressed as percentage of enzyme activity inhibition. IC50 
indicating the concentration required to inhibit 50 % LOX activity 
was also calculated. Values of hydroperoxide content and 
lipoxygenase activity were calculated from equation,  
Specific activity (LOX) =∆A. V/ε.l.c  
where, ∆A is the value of absorbance increase per min, V is the 
volume of incubation mixture, ε is the extinction coefficient for 
linoleic acid (25 x 10-3 mol/l/cm) [23], l is the length of the cuvette 
(1 cm) and c is the concentration of enzyme in mg (0.005). The 
values are mean of three independent experiments.  
Human cyclooxygenase (COX-2) inhibition 
COX-2 inhibition was measured using a colorimetric human COX-2 
inhibitor screening assay kit (Cayman Ann Arbor, MI, USA). The 
methanolic extract (10 and 50 µg) was used for inhibition studies as per 
manufacturer’s protocol. The absorbance at 415 nm was read by using a 
microtitre plate reader Varioskan Flash with SkanIt Software 2.4.3 RE.  
DNA protection studies 
A DNA nicking assay was performed by using supercoiled pBR 322 
plasmid [24]. Controls consisted of plasmid DNA subjected to 
reaction with Fenton reagent for 30 min under similar conditions. 
DNA protection effects against Fenton reagent was assessed by 
incubating methanolic extract (10 µg) with plasmid DNA (0.5 µg) for 
30 min at 37oC and further to Fenton reagent for 30 min. The 
samples were electrophoresed in 1% agarose gel. The results were 
documented using XR+ Molecular Imager Gel documentation system 
(Bio Rad, USA).  
Statistical analysis 
All determinations including antioxidant capacity by DPPH ., 
ABTS.+, total phenolic content, anti-microbial activity, lipoxygenase 
inhibition assay, COX-2 and DNA nicking assay were conducted in 
triplicate. The reported value for each sample was calculated as 
the mean and standard deviation of three independent 
experiments. 
RESULTS 
Antioxidant properties and total phenol content 
The methanolic extracts of Memecylon spp. could scavenge free 
radicals in a concentration-dependent manner. The results were 
expressed as IC50 value indicating the concentration of the 
methanolic extract required to scavenge 50 % of DPPH. and ABTS.+.  
In DPPH assay M. malabaricum extract was most potent exhibiting 
IC50 of 0.11 ± 0.5 mg/mL followed by M. umbellatum with IC50 of 0.14 
± 0.61 mg/mL. The IC50 for TAC was 0.17 ± 0.4 mg/mL for M. 
talbotianum. The TAC of reference standards quercetin, butylated 
hydroxyl toluene (BHT) and ascorbic acid under similar conditions of 
the experiment were analyzed. The IC50 values for scavenging DPPH. 
radical for quercetin, BHT and ascorbic acid were 5.2 ± 1.24 µg/mL, 
13.34 ± 1.21µg/mL and 30.32 ± 0.36µg/mL respectively (Table 1).  
Antioxidant activity measured by ABTS.+ method indicated that 
methanolic extract of M. malabaricum had IC50 of 2.1 ± 0.21 mg/mL. 
M. umbellatum and M. talbotianum leaves exhibited TAC with IC50 of 
2.3 ± 0.22 mg/mL and IC50 of 3.7 ± 1.13 mg/mL respectively. The IC50 
values for TAC with respect to the reference compounds quercetin 
was 6.13 ± 0.66 µg/mL, ascorbic acid was IC50 of 76.4 ± 0.13 µg/mL 
and BHT exhibited IC50 of 19.2 ± 1.01 µg/mL capacity to scavenge 
ABTS.+ (Table 1). 
The amount of total phenolic content was estimated by Folin–
Ciocalteu spectrophotometric method and reported as gallic acid 
equivalent/100 g dry weight (g GAE/100g DW). Among the leaf 
extracts, M. talbotianum leaves had a higher total phenolic content of 
1.12 ± 0.18 g GAE/100g DW. The leaves of M. umbellatum had 1.08 ± 
0.16 g GAE/100g DW of phenolic content. The M. malabaricum leaves 
had 1.96 ± 0.49 g GAE/100g DW of phenolic content (Table 1). 
Anti-microbial activity 
In the present study all the extracts exhibited antimicrobial activity 
to various extents. The most effective extract tested was of M. 
malabaricum exhibiting clear effects on Klebsiella pneumonia, 
Staphylococcus aureus and Escherichia coli and had moderate effects 
on Bacillus subtillis. M. umbellatum leaves could slightly inhibit 
growth of K. pneumonia, E. coli, S. typhi and B. subtilis. M. talbotianum 
leaf extract showed clear and moderate anti-microbial activity 
against E. coli and K. pneumonia (Table 2).  
15-lipoxygenase and human COX-2 inhibition activity 
The LOX activity was monitored as an increase in the absorbance 
at 234 nm indicating the formation of hydroperoxylinoleic acid. All 
the Memecylon spp. leaf extract tested inhibited LOX in a 
concentration dependent manner. The highest inhibitory effect 
was observed for M. malabaricum with an IC50 of 29.87 µg/mL 
(Table 3). The M. umbellatum extract inhibited LOX with IC50 of 39 
µg/mL. Amongst the three extracts M. talbotianum leaf extract 
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inhibited 96% of LOX activity at 200 µg/mL and at a relatively 
higher IC50 value of 54.6 µg/mL (Table 3). Complete LOX inhibition 
was observed at a concentration of 250 µg. Human COX-2 
inhibition revealed a dose dependent pattern with M. malabaricum 
inhibiting 80.58% at 50 µg of extract. At the same concentration M. 
umbellatum and M. talbotianum inhibited 43.8% and 43% 
respectively (Table 4).  
DNA protection studies  
In this assay pBR322 plasmid DNA was exposed to Fenton reaction 
for 30 min at 37oC. It caused a change in native double stranded DNA 
band (Form I) to single-stranded, nicked plasmid DNA (Form II) 
initiating a differential pattern in agarose gel (Fig.1). Upon 
incubation of the plasmid DNA with 25 µg of methanolic extract for 
30 min at 37oC and further exposure to Fenton reagent under similar 
conditions as above, the scission of plasmid DNA was reduced or 
absent (Fig.1). Thus methanolic extracts had the capacity to 
scavenge the .OH radicals produced by Fenton reagent protecting the 
pBR322 plasmid DNA. Of the different Memecylon spp. leaf extracts 
of M. umbellatum and M. malabaricum could effectively scavenge the 
potent free radicals. An absence or reduction in Form II and an 
increased Form I recorded indicated a notable protection offered by 
these test samples of medicinal plants.  
 
DISCUSSION 
Traditional knowledge of medicinal plants has clues to unknown 
potential novel drug molecules in the form of secondary metabolites 
[25]. Medicinal plant parts are rich in phenolic compounds, such as 
flavonoids, phenols (alkaloids, amines, betalains), terpenoids (eg., 
carotenoids) stilbenes, tannins, coumarins, lignans and lignins [20, 
26]. Many secondary metabolites are used in pharmaceutical and 
food industry for their capacity to retard oxidative degradation of 
lipids, quench free radicals, chelate metals and improve nutritional 
quality of processed food [27].  
Free radical(s) are oxygen-centered with at least one unpaired 
electron and are end products of several physiological and 
biochemical processes. They attack and damage cell membrane, cell 
organelles and DNA resulting in faulty translation of genetic 
information. This is implicated in contributing to cancer, 
atherosclerosis, aging, immunosuppression, inflammation, diabetes, 
neurodegenerative disorder etc.  
Many plant species show antioxidant properties [28, 29]. The 
antioxidant capacities of the plant extracts largely depend on the 
composition of the extracts. DPPH, scavenging gave reliable 
information concerning the antioxidant ability of the tested 
compounds. ABTS.+ scavenging is also a recommended method for 
detecting the antioxidant potential for plant extracts as 
measurement at 734nm (long wavelength) eliminates colour 
interference by plant extracts20. The antioxidant capacity for the 
methanolic extract of Memecylon spp. reported as IC50 values for 
scavenging DPPH. ranged from 0.11 to 0.17 mg/ml and for ABTS.+ 
the IC50 values ranged from 2.1 to 3.7 mg/ml. The methanolic 
extract of M. malabaricum leaves recorded the lowest IC50 of 0.11 ± 
0.5 and 2.1 ± 0.21 mg/ml for scavenging DPPH. and ABTS.+ 
respectively (Table 1). The potential of medicinal plants 
antioxidant activity could be credited to the phenols in them. 
There is a large diversity of phenolic compounds in medicinal 
plants with antioxidant activity which may contribute to anti-
cancer, anti-bacterial, anti-viral or anti-inflammatory activities to 
a greater extent [17, 29]. It is hypothesized that biological activity 
depends on the number and position of certain hydroxyl groups 
and other substituents in these molecules [30]. Total phenolic 
content of Memecylon spp. estimated in the present study could 
explain the antioxidant potential of the plant extracts. Studies have 
related plants richer in minerals and phenolic compounds with 
potent radical scavenging activity [31]. 
In the present study all the extracts exhibited antimicrobial activity 
to various extents (Table 2). It could be attributed to the presence of 
secondary metabolites as suggested in previous reports [32]. In a 
recent study the M. umbellatum leaves inhibited Gram (-) bacteria 
[9]. Similarly, medicinal plants used in treatments have been tested 
for antimicrobial activity [33, 34, 35]. Essential oil from Tanacetum 
polycephalum traditionally used in treatment of arthritis and 
psoriasis, also exhibited bactericidal activity against pathogenic 
bacteria [33]. Stem bark extracts from Alafia multiflora traditionally 
applied on wounds and leg ulcers exhibited good anti-bacterial 
activity [34]. Lipoxygenases (LOXs) (LOX; EC 1.13.11.12) are a 
family of non-heme iron-containing dioxygenases catalyzing the 
biosynthesis of leukotrienes. Leukotrienes function as initiators of 
inflammation and their inhibition is considered to be partly 
responsible for the anti-inflammatory activity [36]. In the present 
study methanolic extracts M. malabaricum showed good anti-LOX 
activity with an IC50 value of 29.87 µg/ml in comparison to M. 
umbellatum and M. talbotianum (Table 3). LOX inhibition was used 
to evaluate anti-inflammatory activity of a few medicinal plants used 
in Limousin country. Filipendula ulmaria (Meadowsweet) recorded 
LOX inhibition with IC50 of 60 µg/ml and Urtica dioica (Nettle) 
methanolic extract inhibited LOX with IC50 of 348 µg/ml [37]. In 
another study, eight methanolic extract out of 18 undomesticated 
plants of South Africa showed significant inhibition of 5-
lipoxygenase (5-LOX) activity. Bidens pilosa extract exhibited IC50 of 
21.8 μg/ml and Emex australis extract recorded IC50 of 81.4 μg/ml 
for LOX inhibition [38].  
LOXs are sensitive to antioxidants as antioxidants are involved in 
inhibition of lipid hydroperoxide formation due to scavenging of 
lipidoxy- or lipidperoxy-radicals. This could lead to less availability 
of lipid hydroperoxide substrate required for LOX catalysis [23]. 
Another hypothesis proposed indicated that inhibition by 
antioxidant could be attained via chelation of its non-heme bound 
iron [39] or by reduction of its ferric form [40], suggesting a 
competitive kind of inhibition as reported for Mahonia aquifolium 
[23]. We would like to speculate that LOX inhibition could be due to 
antioxidant properties of the methanolic extract with the 
mechanism of action to be elucidated. Previous studies suggested 
that compounds with antioxidant or anti-inflammatory activities 
inhibit tumor promotion and cell proliferation [41]. DNA involved in 
replication and transcription represents the most targeted 
macromolecule. Hydroxyl radicals (.OH) are produced in mammalian 
cells, catalyzed by transition metals (e.g., Fe[II] ions generated via 
reduction of Fe[III] by O.2- in the presence of H2O2 via the Fenton 
reaction). DNA strand breaks can occur when the deoxyribose chain 
interacts with .OH radicals [42]. Most anti-cancer agents are believed 
to act mainly by quenching the free radicals or by direct interaction 
with DNA [17]. In the present study the preincubation of the circular 
plasmid DNA with 25 µg of methanolic extract of Memecylon spp. 
protected the DNA from nicking (Fig. 1). Protection offered could be 
mediated through ability of extracts to quench the .OH radicals 
produced by Fenton reaction.  
Memecylon spp. has been used to treat skin problems with strong 
anti-inflammatory and analgesic activity [43]. In the present study, 
all the three species of Memecylon leaves exhibited antioxidant 
activities credited to the presence of high phenolic content in the 
samples. Earlier studies on Memecylon have reported a broad 
spectrum anti-microbial activity for the methanolic extracts [9, 14]. 
The present work confirms the same against human bacterial 
pathogens. Among the different species of Memecylon screened, M. 
malabaricum leaves exhibited potent LOX and human COX-2 
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inhibition capacity in vitro thereby inhibiting PGE2 production. As 
inhibition of these inflammatory mediators is considered in part 
treatment for inflammation [35] this study partially confirms 
traditionally reported anti-inflammatory capacity of Memecylon spp. 
Reports on “dual inhibitors” inhibiting LOX and COX-2 for effective 
management of metabolic processes underlying osteoarthritis with a 
balanced arachidonic acid metabolism in the body has been 
highlighted [44-48]. The leaf extracts scavenged .OH radicals 
produced during Fenton reaction as assessed for their capacity to 
protect DNA.  
 
Table 1: Antioxidant activity and total phenolic content of Memecylon extracts 
Medicinal plant Total phenolic contenta  Total antioxidant capacity (%TAC)b 
  DPPH ( IC50) ABTS (IC50) 
Ascorbic acid  30.32 ± 0.36 µg/ml 76.4 ± 0.13 µg/ml 
Quercetin  5.2 ± 1.24 µg/ml 6.13 ± 0.66 µg/ml 
BHT  13.34 ± 1.21 µg/ml 19.2 ± 1.01 µg/ml 
Memecylon umbellatum  1.08 ± 0.16 0.14 ± 0.61 mg/ml 2.3 ± 0.22 mg/ml 
M. talbotianum 1.12 ± 0.18 0. 17 ± 0.4 mg/ml 3.7 ± 1.13 mg/ml 
M. malabaricum  1.96 ± 0.49 0.11 ± 0.5 mg/ml 2. 1 ± 0.21 mg/ml 
a Total phenolic content is expressed in grams (g) gallic acid equivalent (GAE)/100g dry weight (DW) 
b Each result is expressed as mean ± S.D. (n = 3) 
 
Table 2: Anti-microbial activity of Memecylon extracts on test microorganisms* 














+++e +++e +++e +++e +++e +++e 
Medicinal plant       
Memecylon umbellatum  ~b -a ~b ~b -a ~b 
M. talbotianum +c ~b ++d ~b -a +c 
M. malabaricum  ++d ++d ++d ~b -a +c 
a = -, no anti-microbial capacity; b = ~ slight anti-microbial capacity, 1-3mm inhibition zone; c = +, moderate anti-microbial capacity, 3-4mm 
inhibition zone; d = ++, clear anti-microbial capacity, 4-10mm inhibition zone; e = +++; clear anti-microbial activity >10mm inhibition zone.  
* The results are representative values of three independent experiments (n=3). 
 
Table 3: Inhibition lipoxygenase activity by Memecylon extracts 
Medicinal plant Final concentration of methanolic extract 
(µg) 
Lipoxygenase specific 



























































Each result is expressed as mean (n = 3); ND- not detected. *Means in the same column followed by a different letter are significantly different (p < 
0.05) according to analysis of variance 
 
Table 4: Inhibition of human cyclooxygenase (COX)-2 activity by Memecylon extracts 
Medicinal plant  Final concentration of methanolic extract (µg/ml) COX-2 inhibition (%)* 












Each result is expressed as mean (n = 3). *Means in the same column followed by the same letter are not significantly different (p < 0.05) according 
to analysis of variance. 
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Effective antioxidant activities for the Memecylon spp. reported in 
the study were observed by assessing their capacity to quench 
DPPH. and ABTS.+ radicals. These activities could be possible due 
to the presence of phenolic compounds. Also observed was 
inhibition of 15-LOX and human COX-2 activities. M. umbellatum 
and M. malabaricum could scavenge hydroxyl radicals and thus 
protect DNA. However, further investigations are required to 
determine the bioactivities in these test samples of medicinal 
plants.  
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